
FDA Guidance Recap Podcast
1 FOLLOWERS
The Guidance Recap Podcast provides highlights for FDA guidance documents straight from the authors. Through conversations with FDA staff, this podcast is intended help communicate salient key points and background information about a subset of cross-cutting guidance documents on topics that seek to modernize and accelerate drug development.
FDA Guidance Recap Podcast
4d ago
Guidance Recap Podcast | Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers ..read more
FDA Guidance Recap Podcast
6d ago
Guidance Recap Podcast | Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs ..read more
FDA Guidance Recap Podcast
6d ago
Guidance Recap Podcast | Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs—Podcast for Patients ..read more
FDA Guidance Recap Podcast
1w ago
Guidance Recap Podcast | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications ..read more
FDA Guidance Recap Podcast
3M ago
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development ..read more
FDA Guidance Recap Podcast
5M ago
Guidance Recap Podcast | In Vitro Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Final Guidance - Podcast Transcript ..read more
FDA Guidance Recap Podcast
5M ago
Guidance Recap Podcast | Multiple Endpoints in Clinical Trials ..read more
FDA Guidance Recap Podcast
5M ago
Thoughts on newly published draft guidance titled, “Ethical Considerations for Clinical Investigations of Medical Products Involving Children ..read more
FDA Guidance Recap Podcast
5M ago
Guidance Recap Podcast: General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products ..read more
FDA Guidance Recap Podcast
5M ago
Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments ..read more